Works about CETUXIMAB

Results: 1707

Adverse event profile of five anti head and neck squamous cell carcinoma drugs: a descriptive analysis from WHO-VigiAccess.

Published in:

Frontiers in Pharmacology, 2025, p. 1, doi. 10.3389/fphar.2025.1602276

By:

Gao, Weimin;
Xia, Zhigang;
Zhou, Tingfeng;
Dong, Youlin

Publication type:

Article

NSC 74859-mediated inhibition of STAT3 enhances the anti-proliferative activity of cetuximab in hepatocellular carcinoma.

Published in:

Liver International, 2012, v. 32, n. 1, p. 70, doi. 10.1111/j.1478-3231.2011.02631.x

By:

Chen, Wei;
Shen, Xuning;
Xia, Xuefeng;
Xu, Guodong;
Ma, Tao;
Bai, Xueli;
Liang, Tingbo

Publication type:

Article

First-in-human intraoperative near-infrared fluorescence imaging of glioblastoma using cetuximab-IRDye800.

Published in:

Journal of Neuro-Oncology, 2018, v. 139, n. 1, p. 135, doi. 10.1007/s11060-018-2854-0

By:

Miller, Sarah E.;
Tummers, Willemieke S.;
Teraphongphom, Nutte;
van den Berg, Nynke S.;
Hasan, Alifia;
Ertsey, Robert D.;
Nagpal, Seema;
Recht, Lawrence D.;
Plowey, Edward D.;
Vogel, Hannes;
Harsh, Griffith R.;
Grant, Gerald A.;
Li, Gordon H.;
Rosenthal, Eben L.

Publication type:

Article

Convection-enhanced delivery of cetuximab conjugated iron-oxide nanoparticles for treatment of spontaneous canine intracranial gliomas.

Published in:

Journal of Neuro-Oncology, 2018, v. 137, n. 3, p. 653, doi. 10.1007/s11060-018-2764-1

By:

Freeman, A. Courtenay;
Platt, Simon R.;
Holmes, Shannon;
Kent, M.;
Robinson, Kelsey;
Howerth, Elizabeth;
Eagleson, Joe;
Bouras, Alexandros;
Kaluzova, Milota;
Hadjipanayis, Constantinos G.

Publication type:

Article

Erratum to: Superselective intraarterial cerebral infusion of cetuximab after osmotic blood/brain barrier disruption for recurrent malignant glioma: phase I study.

Published in:

2016

By:

Chakraborty, Shamik;
Filippi, Christopher;
Wong, Tamika;
Ray, Ashley;
Fralin, Sherese;
Tsiouris, A.;
Praminick, Bidyut;
Demopoulos, Alexis;
McCrea, Heather;
Bodhinayake, Imithri;
Ortiz, Rafael;
Langer, David;
Boockvar, John

Publication type:

Erratum

Superselective intraarterial cerebral infusion of cetuximab after osmotic blood/brain barrier disruption for recurrent malignant glioma: phase I study.

Published in:

Journal of Neuro-Oncology, 2016, v. 128, n. 3, p. 405, doi. 10.1007/s11060-016-2099-8

By:

Chakraborty, Shamik;
Filippi, Christopher;
Wong, Tamika;
Ray, Ashley;
Fralin, Sherese;
Tsiouris, A.;
Praminick, Bidyut;
Demopoulos, Alexis;
McCrea, Heather;
Bodhinayake, Imithri;
Ortiz, Rafael;
Langer, David;
Boockvar, John

Publication type:

Article

Can cetuximab affect paraneoplastic myopathy?

Published in:

Journal of Neuro-Oncology, 2009, v. 93, n. 3, p. 437, doi. 10.1007/s11060-009-9795-6

By:

Eleni Galani;
Anastasios Bonakis;
Christos Christodoulou;
George Klouvas;
Drougou Angeliki;
Dimostenis Skarlos

Publication type:

Article

Analysis of main pathogenic bacteria and drug sensitivity in patients with chronic suppurative otitis media and middle ear cholesteatoma in China.

Published in:

Biotechnology Letters, 2020, v. 42, n. 8, p. 1559, doi. 10.1007/s10529-020-02880-7

By:

Xu, Feng;
Kong, Weili;
Peng, Jiaojiao;
Gu, Hailing;
Zheng, Hong

Publication type:

Article

Inhibition of autophagy enhances the anticancer effect of Schisandrin B on head and neck squamous cell carcinoma.

Published in:

Journal of Biochemical & Molecular Toxicology, 2024, v. 38, n. 1, p. 1, doi. 10.1002/jbt.23585

By:

Li, Mengmeng;
Tang, Qinglai;
Li, Shisheng;
Yang, Xinming;
Zhang, Ying;
Tang, Xiaojun;
Huang, Peiying;
Yin, Danhui

Publication type:

Article

Impact of second-line and later cetuximab-containing therapy and KRAS genotypes in patients with metastatic colorectal cancer: a multicenter study in Japan.

Published in:

Surgery Today, 2014, v. 44, n. 8, p. 1457, doi. 10.1007/s00595-013-0716-0

By:

Saeki, Hiroshi;
Emi, Yasunori;
Kumashiro, Ryuichi;
Otsu, Hajime;
Kawano, Hiroyuki;
Ando, Koji;
Ida, Satoshi;
Kimura, Yasue;
Tokunaga, Eriko;
Oki, Eiji;
Morita, Masaru;
Shimokawa, Mototsugu;
Maehara, Yoshihiko

Publication type:

Article

Standard diametric versus volumetric early tumor shrinkage as a predictor of survival in metastatic colorectal cancer: subgroup findings of the randomized, open-label phase III trial FIRE-3 / AIO KRK-0306.

Published in:

European Radiology, 2023, v. 33, n. 2, p. 1174, doi. 10.1007/s00330-022-09053-2

By:

Hofmann, Felix O.;
Heinemann, Volker;
D'Anastasi, Melvin;
Gesenhues, Alena B.;
Hesse, Nina;
von Weikersthal, Ludwig Fischer;
Decker, Thomas;
Kiani, Alexander;
Moehler, Markus;
Kaiser, Florian;
Heintges, Tobias;
Kahl, Christoph;
Kullmann, Frank;
Scheithauer, Werner;
Link, Hartmut;
Modest, Dominik P.;
Stintzing, Sebastian;
Holch, Julian W.

Publication type:

Article

Posters.

Published in:: 2008
Publication type:: Abstract

Monoclonaux contre TKI A pour les anti-REGF.

Published in:

Oncologie (Tech Science Press), 2006, v. 8, n. 9, p. 842, doi. 10.1007/s10269-006-0522-z

By:

Bozec, A.;
Dassonville, O.;
Poissonnet, G.;
Peyrade, F.;
Fischel, J.-L.;
Milano, G.

Publication type:

Article

Quelles nouvelles stratégies dans le traitement du cancer colorectal métastatique avec les biothérapies?

Published in:

Oncologie (Tech Science Press), 2005, v. 7, n. 8, p. 603, doi. 10.1007/s10269-005-0309-7

By:

Tournigand, C.;
Louvet, C.;
André, T.;
De Gramont, A.

Publication type:

Article

Impact of the Specific Mutation in KRAS Codon 12 Mutated Tumors on Treatment Efficacy in Patients with Metastatic Colorectal Cancer Receiving Cetuximab-Based First-Line Therapy: A Pooled Analysis of Three Trials.

Published in:

Oncology, 2012, v. 83, n. 5, p. 241, doi. 10.1159/000339534

By:

Modest, Dominik P.;
Brodowicz, Thomas;
Stintzing, Sebastian;
Jung, Andreas;
Neumann, Jens;
Laubender, Ruediger P.;
Ocvirk, Janja;
Kurteva, Galina;
Papai, Zsuzsanna;
Knittelfelder, Regina;
Kirchner, Thomas;
Heinemann, Volker;
Zielinski, Christoph C.

Publication type:

Article

The Role of Antiangiogenic Agents in the Treatment of Head and Neck Cancer.

Published in:

Oncology, 2012, v. 83, n. 2, p. 108, doi. 10.1159/000339542

By:

Denaro, N.;
Russi, E.G.;
Colantonio, I.;
Adamo, V.;
Merlano, M.C.

Publication type:

Article

Clinical Benefit of High-Sensitivity KRAS Mutation Testing in Metastatic Colorectal Cancer Treated with Anti-EGFR Antibody Therapy.

Published in:

Oncology, 2012, v. 82, n. 5, p. 298, doi. 10.1159/000336792

By:

Kimura, Tetsuo;
Okamoto, Koichi;
Miyamoto, Hiroshi;
Kimura, Masako;
Kitamura, Shinji;
Takenaka, Hidetaka;
Muguruma, Naoki;
Okahisa, Toshiya;
Aoyagi, Eriko;
Kajimoto, Mayumi;
Tsuji, Yasushi;
Kogawa, Takahiro;
Tsuji, Akihito;
Takayama, Tetsuji

Publication type:

Article

Genetic Polymorphisms of FcγRIIa and FcγRIIIa Are Not Predictive of Clinical Outcomes after Cetuximab plus Irinotecan Chemotherapy in Patients with Metastatic Colorectal Cancer.

Published in:

Oncology, 2012, v. 82, n. 2, p. 83, doi. 10.1159/000335959

By:

Park, Seong Joon;
Hong, Yong Sang;
Lee, Jae-Lyun;
Ryu, Min-Hee;
Chang, Heung Moon;
Kim, Kyu-pyo;
Ahn, Yong Chel;
Na, Young-Soon;
Jin, Dong-Hoon;
Yu, Chang Sik;
Kim, Jin Cheon;
Kang, Yoon-Koo;
Kim, Tae Won

Publication type:

Article

Prolonged Survival of Patients with Metastatic Colorectal Cancer following First-Line Oxaliplatin-Based Chemotherapy with Molecular Targeting Agents and Curative Surgery.

Published in:

Oncology, 2011, v. 81, n. 3/4, p. 167, doi. 10.1159/000333404

By:

Shitara, Kohei;
Matsuo, Keitaro;
Kondo, Chihiro;
Takahari, Daisuke;
Ura, Takashi;
Inaba, Yoshitaka;
Yamaura, Hidekazu;
Sato, Yozo;
Kato, Mina;
Kanemitsu, Yukihide;
Komori, Koji;
Ishiguro, Seiji;
Sano, Tsuyoshi;
Shimizu, Yasuhiro;
Muro, Kei

Publication type:

Article

KRAS Mutation in Metastatic Pancreatic Ductal Adenocarcinoma: Results of a Multicenter Phase II Study Evaluating Efficacy of Cetuximab plus Gemcitabine/Oxaliplatin (GEMOXCET) in First-Line Therapy.

Published in:

Oncology, 2011, v. 81, n. 1, p. 3, doi. 10.1159/000330194

By:

Kullmann, F.;
Hartmann, A.;
Stöhr, R.;
Messmann, H.;
Dollinger, M.M.;
Trojan, J.;
Fuchs, M.;
Hollerbach, S.;
Harder, J.;
Troppmann, M.;
Kutscheidt, A.;
Endlicher, E.

Publication type:

Article

Reply to Dr. Kabbinavar and Dr. Kozloff.

Published in:

Oncology, 2011, v. 80, n. 1/2, p. 140, doi. 10.1159/000327226

By:

Stathopoulos, G.P.

Publication type:

Article

Cetuximab plus FOLFOX-4 in Untreated Patients with Advanced Colorectal Cancer: A Gruppo Oncologico dell'Italia Meridionale Multicenter Phase II Study.

Published in:

Oncology, 2011, v. 79, n. 5/6, p. 415, doi. 10.1159/000323279

By:

Colucci, Giuseppe;
Giuliani, Francesco;
Garufi, Carlo;
Mattioli, Rodolfo;
Manzione, Luigi;
Lopez, Massimo;
Parrella, Paola;
Tommasi, Stefania;
Copetti, Massimiliano;
Daniele, Bruno;
Pisconti, Salvatore;
Tuveri, Guido;
Silvestris, Nicola;
Maiello, Evaristo;
Russo, Antonio

Publication type:

Article

The Long and Winding Road to Useful Predictive Factors for Anti-EGFR Therapy in Metastatic Colorectal Carcinoma: The KRAS/BRAF Pathway.

Published in:

Oncology, 2009, v. 77, p. 57, doi. 10.1159/000258497

By:

Russo, Antonio;
Rizzo, Sergio;
Bronte, Giuseppe;
Silvestris, Nicola;
Colucci, Giuseppe;
Gebbia, Nicola;
Bazan, Viviana;
Fulfaro, Fabio

Publication type:

Article

The Dark Side of the Moon: The PI3K/PTEN/AKT Pathway in Colorectal Carcinoma.

Published in:

Oncology, 2009, v. 77, p. 69, doi. 10.1159/000258498

By:

Silvestris, Nicola;
Tommasi, Stefania;
Petriella, Daniela;
Santini, Daniele;
Fistola, Ettore;
Russo, Antonio;
Numico, Gianmauro;
Tonini, Giuseppe;
Maiello, Evaristo;
Colucci, Giuseppe

Publication type:

Article

The Role of KRAS Mutations in Predicting the Efficacy of Cetuximab-Plus-Irinotecan Therapy in Irinotecan-Refractory Korean Metastatic Colorectal Cancer Patients.

Published in:

Oncology, 2009, v. 77, n. 3/4, p. 224, doi. 10.1159/000236046

By:

Byeong Seok Sohn;
Tae Won Kim;
Jae-Lyun Lee;
Min-Hee Ryu;
Heung Moon Chang;
Yoon-Koo Kang;
Hyo Suk Park;
Young-Soon Na;
Se Jin Jang;
Jin Cheon Kim;
Jung Shin Lee

Publication type:

Article

Clinical Predictors of Severe Cetuximab-Induced Rash: Observations from 933 Patients Enrolled in North Central Cancer Treatment Group Study N0147.

Published in:

Oncology, 2009, v. 77, n. 2, p. 120, doi. 10.1159/000229751

By:

Jatoi, Aminah;
Green, Erin M.;
Rowland Jr., Kendrith M.;
Sargent, Daniel J.;
Alberts, Steven R.

Publication type:

Article

Risk of High-Grade Skin Rash in Cancer Patients Treated with Cetuximab – an Antibody against Epidermal Growth Factor Receptor: Systemic Review and Meta-Analysis.

Published in:

Oncology, 2009, v. 77, n. 2, p. 124, doi. 10.1159/000229752

By:

Xiao Su;
Lacouture, Mario E.;
Yuxia Jia;
Shenhong Wu

Publication type:

Article

Response to Reintroduction of Cetuximab in 5 Patients with Advanced, Chemotherapy-Resistant, Colorectal Cancer without Progressive Disease following First-Line Therapy with a Cetuximab-Containing Regimen.

Published in:

Oncology, 2008, v. 74, n. 3/4, p. 123, doi. 10.1159/000151358

By:

Kaechele, Volker;
von Wichert, Goetz;
Adler, Guido;
Seufferlein, Thomas

Publication type:

Article

Assessment of Baseline Clinical Predictive Factors of Response to Cetuximab-Irinotecan in Patients with Irinotecan-Refractory Metastatic Colorectal Cancer.

Published in:

Oncology, 2007, v. 73, n. 3/4, p. 185, doi. 10.1159/000127385

By:

Hebbar, Mohamed;
Di Fioré, Frédéric;
Conroy, Thierry;
Giraud, Claire;
Gasnault, Laurent;
Fournier, Charles;
Péreira, Renata;
Bouché, Olivier;
Fournier, Peggy;
Deligny, Nathalie;
Joly, Jean-Paul;
Maes, Patricia;
Rad, Emilia;
Michel, Pierre;
Adenis, Antoine

Publication type:

Article

Feasibility of Using Cetuximab and Bevacizumab in a Patient with Colorectal Cancer and Terminal Renal Failure.

Published in:

Oncology, 2007, v. 72, n. 3/4, p. 209, doi. 10.1159/000112828

By:

Inauen, R.;
Cathomas, R.;
Boehm, T.;
Koeberle, D.;
Pestalozzi, B. C.;
Gillessen, S.;
Von Moos, R.

Publication type:

Article

Cetuximab plus Gemcitabine-Oxaliplatin (GEMOX) in Patients with Refractory Advanced Intrahepatic Cholangiocarcinomas.

Published in:

Oncology, 2007, v. 72, n. 1/2, p. 105, doi. 10.1159/000111117

By:

Paule, Bernard;
Herelle, Marie-Olga;
Rage, Estelle;
Ducreux, Michel;
Adam, René;
Guettier, Catherine;
Bralet, Marie-Pierre

Publication type:

Article

Recurrent Poorly Differentiated Thyroid Cancer Successfully Treated With Radiation and Immunotherapy.

Published in:

2025

By:

Hamidi, Sarah;
Ning, Matthew S;
Phan, Jack;
Zafereo, Mark E;
Gule-Monroe, Maria K;
Dadu, Ramona

Publication type:

Case Study

Inhibition of N-acetylglucosaminyltransferase V enhances the cetuximab-induced radiosensitivity of nasopharyngeal carcinoma cells likely through EGFR N-glycan alterations.

Published in:

Glycobiology, 2017, v. 27, n. 8, p. 713, doi. 10.1093/glycob/cwx046

By:

Xiaomin Huang;
Ting Liu;
Qiongyao Wang;
Weiliang Zhu;
Hui Meng;
Linlang Guo;
Ting Wei;
Jian Zhang

Publication type:

Article

EndoS and EndoS2 hydrolyze Fc-glycans on therapeutic antibodies with different glycoform selectivity and can be used for rapid quantification of high-mannose glycans.

Published in:

Glycobiology, 2015, v. 25, n. 10, p. 1053, doi. 10.1093/glycob/cwv047

By:

Sjögren, Jonathan;
Cosgrave, Eoin F. J.;
Allhorn, Maria;
Nordgren, Maria;
Björk, Stephan;
Olsson, Fredrik;
Fredriksson, Sarah;
Collin, Mattias

Publication type:

Article

Correction: HOXB8 mediates resistance to cetuximab in colorectal cancer cells through activation of the STAT3 pathway.

Published in:

2025

By:

Liang, Yunan;
Lin, Han;
Jiang, Zongsheng;
Zhao, Qi;
Cui, Ri;
Li, Shaotang

Publication type:

Correction Notice

Commentary: on Encorafenib plus cetuximab in patients with BRAFV600E-mutated metastatic colorectal cancer -- Polish multicenter experience.

Published in:

Oncology in Clinical Practice (2450-1654), 2024, v. 20, n. 4, p. 308, doi. 10.5603/ocp.97067

By:

Radecka, Barbara

Publication type:

Article

Encorafenib plus cetuximab in patients with BRAF<sub>V600E</sub>-mutated metastatic colorectal cancer -- Polish multicenter experience.

Published in:

Oncology in Clinical Practice (2450-1654), 2024, v. 20, n. 4, p. 264, doi. 10.5603/ocp.98519

By:

Gełej, Marek;
Zając, Patryk;
Dąbrowska, Maria;
Drejws-Wątróbska, Anna;
Galińska, Bogumiła;
Galus, Łukasz;
Gwóźdź-Cieślik, Agnieszka;
Hetman, Katarzyna;
Kawecki, Maciej;
Malik, Mateusz;
Streb, Joanna;
Wierzbicka, Katarzyna;
Wiosek, Piotr;
Radecka, Barbara

Publication type:

Article

CA72-4 as a promising prognostic and diagnostic biomarker in Iraqi patients with colorectal cancer.

Published in:

Al-Mustansiriyah Journal of Science, 2023, v. 34, n. 1, p. 10, doi. 10.23851/mjs.v34i1.1198

By:

Sabbar, Mortada Basheer;
Zeiny, Sarmad Mohammad;
Ibrahim, Mazin Judy

Publication type:

Article

De-escalation of the systemic therapy in advanced colorectal cancer – justified clinical practice from the point of view of efficiency and safety.

Published in:

Nowotwory, 2021, v. 71, n. 5, p. 303, doi. 10.5603/NJO.2021.0055

By:

Grela-Wojewoda, Aleksandra;
Pacholczak-Madej, Renata;
Wysocki, Wojciech M.;
Ziobro, Marek

Publication type:

Article

From Bench to Bedside: A Team's Approach to Multidisciplinary Strategies to Combat Therapeutic Resistance in Head and Neck Squamous Cell Carcinoma.

Published in:

Journal of Clinical Medicine, 2024, v. 13, n. 20, p. 6036, doi. 10.3390/jcm13206036

By:

Crossman, Bridget E.;
Harmon, Regan L.;
Kostecki, Kourtney L.;
McDaniel, Nellie K.;
Iida, Mari;
Corday, Luke W.;
Glitchev, Christine E.;
Crow, Madisen T.;
Harris, Madelyn A.;
Lin, Candie Y.;
Adams, Jillian M.;
Longhurst, Colin A.;
Nickel, Kwangok P.;
Ong, Irene M.;
Alexandridis, Roxana A.;
Yu, Menggang;
Yang, David T.;
Hu, Rong;
Morris, Zachary S.;
Hartig, Gregory K.

Publication type:

Article

Uncommon Blepharitis.

Published in:

Journal of Clinical Medicine, 2024, v. 13, n. 3, p. 710, doi. 10.3390/jcm13030710

By:

Di Zazzo, Antonio;
Giannaccare, Giuseppe;
Villani, Edoardo;
Barabino, Stefano

Publication type:

Article

NIR Photodynamic Destruction of PDAC and HNSCC Nodules Using Triple-Receptor-Targeted Photoimmuno-Nanoconjugates: Targeting Heterogeneity in Cancer.

Published in:

Journal of Clinical Medicine, 2020, v. 9, n. 8, p. 2390, doi. 10.3390/jcm9082390

By:

Bano, Shazia;
Obaid, Girgis;
Swain, Joseph W. R.;
Yamada, Marina;
Pogue, Brian W.;
Wang, Kenneth;
Hasan, Tayyaba

Publication type:

Article

Systematic Review of Variations in Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Peritoneal Metastasis from Colorectal Cancer.

Published in:

Journal of Clinical Medicine, 2018, v. 7, n. 12, p. 567, doi. 10.3390/jcm7120567

By:

Yurttas, Can;
Hoffmann, Giulia;
Tolios, Alexander;
Haen, Sebastian P.;
Schwab, Matthias;
Königsrainer, Ingmar;
Königsrainer, Alfred;
Beckert, Stefan;
Löffler, Markus W.

Publication type:

Article

Cetuximab Plus Methotrexate in Recurrent and/or Metastatic Head-and-Neck Squamous Cell Carcinoma.

Published in:

Journal of Cancer Research & Practice, 2023, v. 10, n. 3, p. 101

By:

Wen-Chen Tang;
Pei-Wei Huang;
Chien-Yu Lin;
Chia-Hsun Hsieh;
Cheng-Lung Hsu;
Shiang-Fu Huang;
Chun-Ta Liao;
Chih-Hua Yeh;
Nai-Ming Cheng;
Hung-Ming Wang

Publication type:

Article

Promising Response with PI3K Inhibitor for a Patient with Heavily Pretreated PIK3CA Mutation Head-and-Neck Cancer.

Published in:

Journal of Cancer Research & Practice, 2023, v. 10, n. 2, p. 75, doi. 10.4103/ejcrp.eJCRP-D-22-00018

By:

Ming-Jing Lee;
Hsiang-Fong Kao

Publication type:

Article

Identification of mitochondria-related action targets of quercetin in melanoma cells.

Published in:

Mitochondrial DNA: Resources, 2023, v. 8, n. 10, p. 1114, doi. 10.1080/23802359.2023.2268775

By:

Xi, Qing;
Li, Li;
Yang, Yongjie;
Li, Liubing;
Zhang, Rongxin

Publication type:

Article

Serum Pro-Inflammatory Cytokines and Leptin as Potential Biomarkers for Treatment Response and Toxicity in Locally Advanced Squamous Cell Carcinoma of the Head and Neck.

Published in:

Diseases, 2024, v. 12, n. 3, p. 55, doi. 10.3390/diseases12030055

By:

Alrehaili, Amani A.;
Gharib, Amal F.;
Bakhuraysah, Maha M.;
Alharthi, Afaf;
Alsalmi, Ohud;
Alsaeedi, Fouzeyyah Ali;
Alhakami, Reem Ali;
Alasmari, Kamilah Ali;
Mohammed, Nuha;
Elsawy, Wael H.

Publication type:

Article

Use of monoclonal antibodies (Bevacizumab, Cetuximab, and Panitumumab) in patients with metastatic colorectal cancer: A single center experience.

Published in:

Journal of Experimental & Clinical Medicine / Deneysel ve Klinik Tip Dergisi, 2022, v. 39, n. 4, p. 1112, doi. 10.52142/omujecm.39.4.34

By:

ŞAHİNGÖZ ERDAL, Gülçin;
GÜLTÜRK, İlkay;
ÖZMEN, Aykut;
YILDIZ TACAR, Seher;
YILMAZ, Mesut;
TURAL, Deniz

Publication type:

Article

Clinical significance of completion of radium-223 treatment and acute adverse events in patients with metastatic castrationresistant prostate cancer.

Published in:

Asia Oceania Journal of Nuclear Medicine & Biology, 2023, v. 11, n. 1, p. 13, doi. 10.22038/AOJNMB.2022.67136.1468

By:

Kazuya Takeda;
Yoshihide Kawasaki;
Toru Sakayauchi;
Chiaki Takahashi;
Yu Katagiri;
Takaya Tanabe;
Yojiro Ishikawa;
Keisuke Fujimoto;
Masaki Kubozono;
Maiko Kozumi;
Keiko Abe;
Kakutaro Narazaki;
Shun Tasaka;
Rei Umezawa;
Takaya Yamamoto;
Noriyoshi Takahashi;
Yu Suzuki;
Keita Kishida;
So Omata;
Akihiro Ito

Publication type:

Article

Identification of the Immune Cell Infiltration Landscape in Head and Neck Squamous Cell Carcinoma (HNSC) for the Exploration of Immunotherapy and Prognosis.

Published in:

Genetics Research, 2022, p. 1, doi. 10.1155/2022/6880760

By:

Huang, Chunli;
Liu, Jifeng

Publication type:

Article